202 related articles for article (PubMed ID: 34272876)
21. Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension.
Yu Y; El-Sayed IH; McDermott MW; Theodosopoulos PV; van Zante A; Kased N; Glastonbury CM; Garsa AA; Yom SS
Laryngoscope; 2018 Oct; 128(10):2226-2233. PubMed ID: 29427378
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract][Full Text] [Related]
23. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
[TBL] [Abstract][Full Text] [Related]
24. Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.
Li R; Tian S; Zhu Y; Yan L; Zhu W; Quan H; Wang S
Radiat Oncol; 2019 Jun; 14(1):107. PubMed ID: 31196122
[TBL] [Abstract][Full Text] [Related]
25. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.
Jiang W; Mohamed ASR; Fuller CD; Kim BYS; Tang C; Gunn GB; Hanna EY; Frank SJ; Su SY; Diaz E; Kupferman ME; Beadle BM; Morrison WH; Skinner H; Lai SY; El-Naggar AK; DeMonte F; Rosenthal DI; Garden AS; Phan J
Pract Radiat Oncol; 2016; 6(4):241-247. PubMed ID: 26979544
[TBL] [Abstract][Full Text] [Related]
26. Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.
Sun Y; Huang Q; Cui S; Wang M; Zhang N; Zhang S; Yang B; Qiu E; Huang Z; Zhou B
World Neurosurg; 2021 Jul; 151():e58-e67. PubMed ID: 33798777
[TBL] [Abstract][Full Text] [Related]
27. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
[TBL] [Abstract][Full Text] [Related]
28. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
[TBL] [Abstract][Full Text] [Related]
29. Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database.
Duo GS; Feng JL; Zhang ZY; Wang LJ
Cancer Radiother; 2022 Sep; 26(5):663-669. PubMed ID: 35249817
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastasis from olfactory neuroblastoma at presentation and as disease relapse: A systematic review and proportion meta-analysis of prevalence data and variables influencing regional control.
Tomasoni M; Marazzi E; Rampinelli V; Mattavelli D; Schreiber A; Deganello A; Piazza C
Head Neck; 2023 Jun; 45(6):1486-1496. PubMed ID: 36995898
[TBL] [Abstract][Full Text] [Related]
31. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
32. Esthesioneuroblastoma: the Northwestern University experience.
Argiris A; Dutra J; Tseke P; Haines K
Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
[TBL] [Abstract][Full Text] [Related]
33. Olfactory Neuroblastoma.
Abdelmeguid AS
Curr Oncol Rep; 2018 Feb; 20(1):7. PubMed ID: 29411144
[TBL] [Abstract][Full Text] [Related]
34. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
[TBL] [Abstract][Full Text] [Related]
35. Neck management in patients with olfactory neuroblastoma.
Song X; Huang C; Wang S; Yan L; Wang J; Li Y
Oral Oncol; 2020 Feb; 101():104505. PubMed ID: 31835073
[TBL] [Abstract][Full Text] [Related]
36. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.
Manthuruthil C; Lewis J; McLean C; Batra PS; Barnett SL
World Neurosurg; 2016 Jun; 90():1-5. PubMed ID: 26899467
[TBL] [Abstract][Full Text] [Related]
38. Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management.
Sakata K; Maeda A; Rikimaru H; Ono T; Koga N; Takeshige N; Tokutomi T; Umeno H; Kiyokawa K; Morioka M
World Neurosurg; 2016 May; 89():240-54. PubMed ID: 26875653
[TBL] [Abstract][Full Text] [Related]
39. Multicenter assessment of exclusive endoscopic endonasal approach for the treatment of 53 olfactory neuroblastomas.
de Gabory L; Verillaud B; Rumeau C; Herman P; Jankowski R; Michel J; de Kermadec H; Coste A; Mortuaire G; Righini C; Reyt E; Choussy O; Trévillot V; Crampette L; Serrano E; Tsaranazy A; Bastier PL; Vergez S
Head Neck; 2018 May; 40(5):1000-1007. PubMed ID: 29356209
[TBL] [Abstract][Full Text] [Related]
40. Olfactory neuroblastomas: survival rate and prognostic factor.
Hwang SK; Paek SH; Kim DG; Jeon YK; Chi JG; Jung HW
J Neurooncol; 2002 Sep; 59(3):217-26. PubMed ID: 12241118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
